El esloveno, tras ganar Giro y Tour en el mismo año, busca el oro en un Mundial en el que las opciones españolas pasan Ayuso, Pello Bilbao y Castrillo Leer

El esloveno logra mejores números que el francés, cuando también tenía 26 años, en las principales pruebas del calendario. Leer

''No he visto a nadie mejor'', coinciden técnicos y corredores, que se rinden ante el talento, la genética privilegiada y la capacidad para mantenerse siempre motivado del esloveno, ganador este curso de 25 carreras Leer

Tim McGraw wants to hear from you!

The U.S. Food and Drug Administration (USFDA) has released a new set of guidelines for the use of already approved Recombinant Human Papillomavirus 9-valent Vaccine in males.

The FDA has cleared Merck’s new Covid-19 therapy molnupiravir, the latest antiviral that adults can take at home to avoid severe disease. WSJ’s Daniela Hernandez explains the science behind the new drug. Photo: Merck

After Merck’s Covid-19 vaccine candidates failed, the drugmaker partnered with rival Johnson & Johnson. WSJ reporter Jared Hopkins takes us behind the scenes, as the first Merck-made shots are released for distribution. Photo: Hannah Yoon/WSJ

Manchester : Manchester University Press, [2016]

Merck has sought a restraint on Indian firm Glenmark on manufacturing and marketing anti-diabetes drugs Zita and Zita-Met.

The pair hopes to stimulate the immune system to tackle tumors bearing mutant KRas proteins, one of cancer’s toughest targets

The first goal is to thwart the outbreak, but researchers also hope for new insights into combating the virus

Kenneth Frazier, the CEO of the pharmaceutical company known as MSD outside of North America, discusses his upbringing and how it influences his leadership as chief executive. He is one of the few African-American CEOs in the Fortune 500, and shot to prominence after resigning from a council advising the Trump White House. Frazier discusses the importance of values in leadership and how Merck thinks about R&D and drug prices.

(United States Supreme Court) - Clarified when federal law will preempt a state law claim that a drug manufacturer failed to warn consumers of a drug's risks. Held that this preemption question is one for a judge to decide, not a jury. Also spelled out the "clear evidence" standard that applies in this context. Justice Breyer, joined by five justices, delivered the U.S. Supreme Court's majority opinion in this product liability lawsuit against a drugmaker.

(United States Federal Circuit) - Affirming the district court's determination that patents relating to aspects of the production of an antibiotic compound were obvious implementations of disclosures made in other patents that would constitute nothing more than the routine way a skilled artisan would apply the patent's teachings.

(United States Federal Circuit) - Affirming the District Court's determination that a proposed generic nasal spray would not infringe the patents of a company manufacturing the Nasonex nasal product.

(United States Federal Circuit) - Affirming the judgment that Merck, initially defending its patent on Hepatitis C drugs against a competitor seeking to have them found invalid, who successfully counter-sued for infringement, had unclean hands regarding the patents and was properly barred from asserting its patents and awarded attorney fees to the plaintiff.

(United States Supreme Court) - Clarified when federal law will preempt a state law claim that a drug manufacturer failed to warn consumers of a drug's risks. Held that this preemption question is one for a judge to decide, not a jury. Also spelled out the "clear evidence" standard that applies in this context. Justice Breyer, joined by five justices, delivered the U.S. Supreme Court's majority opinion in this product liability lawsuit against a drugmaker.

Dr Mike England joins as medical director for UK & ROI

The partnership will focus on generating novel small-molecule inhibitors against specific DUB targets for treatment of a range of diseases.

Germany’s science and technology company Merck KGaA today announced its investment in SynSense (formerly…

American pharmaceutical company Merck, Sharp &.

American pharmaceutical company Merck, Sharp & Dohme was sentenced by U.S. District Court Judge Patti B. Saris in Boston to pay a criminal fine in the amount of $321,636,000 in connection with its guilty plea related to its promotion and marketing of the painkiller Vioxx (rofecoxib), the Justice Department announced today.

Tim McGraw wants to hear from you!

Tim McGraw wants to hear from you!

The most successful cyclist in history, Eddy Merckx, is in intensive care after falling during a bike ride with friends. He was admitted to Dendermonde hospital in Belgium on Sunday.

The technique, called MicroMapping, identifies potential protein interactions on and between cells

The pair hopes to stimulate the immune system to tackle tumors bearing mutant KRas proteins, one of cancer’s toughest targets

The first goal is to thwart the outbreak, but researchers also hope for new insights into combating the virus